These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 8968866)

  • 1. The changes in the rat parotid glands following total parenteral nutrition and pancreatico-biliary diversion are not mediated by cholecystokinin.
    Axelson J; Fan BG; Ohlsson B; Rehfeld J; Ekelund M; Ihse I
    Int J Pancreatol; 1996 Oct; 20(2):109-18. PubMed ID: 8968866
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Total parenteral nutrition affects the tropic effect of cholecystokinin on the exocrine pancreas.
    Fan BG; Axelson J; Sternby B; Rehfeld J; Ihse I; Ekelund M
    Scand J Gastroenterol; 1997 Apr; 32(4):380-6. PubMed ID: 9140162
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of intermittent injections of CCK-8S and the CCK-A receptor antagonist devazepide on cell proliferation in exocrine rat pancreas.
    Ohlsson B; Borg K; Rehfeld JF; Ihse I; Axelson J
    Int J Pancreatol; 1998 Dec; 24(3):211-8. PubMed ID: 9873956
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The trophic effect of cholecystokinin on the pancreas declines in rats on total parenteral nutrition.
    Wu XM; Liao YW; Ji KQ; Li GF; Zang B
    J Anim Physiol Anim Nutr (Berl); 2012 Apr; 96(2):214-9. PubMed ID: 21438927
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CCK stimulates growth of both the pancreas and the liver.
    Ohlsson B; Rehfeld JF; Axelson J
    Int J Surg Investig; 1999; 1(1):47-54. PubMed ID: 11817337
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pancreatic growth after pancreatico-biliary diversion does not increase the capacity to secrete amylase.
    Axelson J; Jansen C; Sternby B; Björkman A; Rehfeld JF; Ihse I
    Eur Surg Res; 1999; 31(2):187-95. PubMed ID: 10213858
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Devazepide-induced hyperplasia in the rat liver and bile ducts.
    Ohlsson B; Axelson J; Rehfeld JF; Ihse I
    Eur Surg Res; 1996; 28(4):299-305. PubMed ID: 8813655
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Portacaval shunt increases the trophic effect of cholecystokinin on the rat pancreas.
    Nylander AG; Chen D; Rehfeld JF; Håkanson R
    Scand J Gastroenterol; 1993 Feb; 28(2):145-8. PubMed ID: 8441908
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The ratio between anionic and cationic trypsin in rat pancreas varies with CCK stimulation.
    Borgström A; Axelson J; Ihse I; Rehfeld JF
    Pancreas; 1995 Aug; 11(2):179-84. PubMed ID: 7479676
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Time-course of the pancreatic changes following long-term stimulation or inhibition of the CCK-A receptor.
    Ohlsson B; Axelson J; Sternby B; Rehfeld JF; Ihse I
    Int J Pancreatol; 1995 Aug; 18(1):59-66. PubMed ID: 7594771
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endogenous cholecystokinin plays a role in down-regulation of pancreatic amylase independent of dietary carbohydrate in rats.
    Hara H; Ohyama S; Hira T
    Regul Pept; 2001 Jun; 99(2-3):103-10. PubMed ID: 11384771
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Continuous infusion of cholecystokinin leads to down-regulation of the cholecystokinin-A receptor in the rat pancreas.
    Ohlsson B; Borg K; Mulder H; Rehfeld JF; Axelson J; Sundler F
    Scand J Gastroenterol; 2000 Jun; 35(6):612-8. PubMed ID: 10912661
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of endogenous and exogenous cholecystokinin and of infusion with the cholecystokinin antagonist L-364,718 on pancreatic and gastrointestinal growth.
    Axelson J; Håkanson R; Ihse I; Lilja I; Rehfeld JF; Sundler F
    Scand J Gastroenterol; 1990 May; 25(5):471-80. PubMed ID: 2359975
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An evaluation of the influence of devazepide and CCK-8S on the intact and resected rat liver.
    Ohlsson B; Rehfeld JF; Axelson J
    Eur Surg Res; 1998; 30(6):378-84. PubMed ID: 9838229
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pancreatic atrophy in rats produced by the cholecystokinin-A receptor antagonist devazepide.
    Nylander AG; Chen D; Ihse I; Rehfeld JF; Håkanson R
    Scand J Gastroenterol; 1992 Sep; 27(9):743-7. PubMed ID: 1411279
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cholecystokinin is not a major determinant for the changes in beta-cell function seen after pancreatico-biliary diversion in rats.
    Gasslander T; Lilja I; Smeds S; Lundquist I; Ihse I
    Diabetes Res; 1991 Nov; 18(3):135-42. PubMed ID: 1841824
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cholecystokinin is responsible for growth of the pancreas after pancreaticobiliary diversion in rats.
    Gasslander T; Axelson J; Håkanson R; Ihse I; Lilja I; Rehfeld JF
    Scand J Gastroenterol; 1990 Oct; 25(10):1060-5. PubMed ID: 2263879
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High-affinity CCK-A receptors on the vagus nerve mediate CCK-stimulated pancreatic secretion in rats.
    Li Y; Hao Y; Owyang C
    Am J Physiol; 1997 Sep; 273(3 Pt 1):G679-85. PubMed ID: 9316472
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The method of administration of cholecystokinin determines the effects evoked in the pancreas.
    Ohlsson B; Borg K; Rehfeld JF; Axelson J; Sundler F
    Pancreas; 2001 Jul; 23(1):94-101. PubMed ID: 11451154
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reduced cholecystokinin mediates the inhibition of pancreatic growth induced by bile salts.
    Gomez G; Townsend CM; Green DW; Rajaraman S; Greeley GH; Thompson JC
    Am J Physiol; 1990 Jul; 259(1 Pt 1):G86-92. PubMed ID: 1695489
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.